Lynx1 Capital Management LP

13F Holdings History for Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

Symbol: PASG on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 624K shares
Security Ownership: 19.6%

Shares, Excluding Options vs Price

Value, Excluding Options

LYNX1 CAPITAL MANAGEMENT LP ownership in Passage BIO, Inc. Common Stock, par value $0.0001 per share (PASG)

2025-11-14 - LYNX1 CAPITAL MANAGEMENT LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 624K shares of Passage BIO, Inc. Common Stock, par value $0.0001 per share (PASG). This represents 19.6% percent ownership of the company. In their previous filing dated 2025-02-14, Lynx1 Capital Management LP had reported owning 9.26M shares, indicating a decrease of -93.3% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
LYNX1 CAPITAL MANAGEMENT LP	19.6%	+30.7%	$206K	624K	-8,633,249	-93.3%	$0.33	13G/A	9/30/2025	14 Nov 2025 14:01:44
Lynx1 Capital Management LP	15%		$3.24M	9.26M			$0.35	13G/A	12/31/2024	14 Feb 2025 09:01:32

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025		-1.07%	$0	0	-9,256,953	-100%		Q3 2025
6/30/2025	1.07%		$3.71M	9.26M			$0.40	Q2 2025
3/31/2025	1.17%		$3.27M	9.26M			$0.35	Q1 2025
12/31/2024	1.97%	+0.18%	$5.25M	9.26M	+829,998	+9.85%	$0.57	Q4 2024
9/30/2024	2.09%	+0.84%	$5.9M	8.43M	+3,369,326	+66.6%	$0.70	Q3 2024
6/30/2024	1.45%	+0.04%	$4.02M	5.06M	+211,758	+4.37%	$0.79	Q2 2024
3/31/2024	1.69%	+2.37%	$6.54M	4.85M	+4,466,712	+1178%	$1.35	Q1 2024
12/31/2023	0.15%	+0.25%	$383K	379K	+379,159	NEW	$1.01	Q4 2023
9/30/2023	0.08%	-0.43%	$125K	190K	-977,219	-83.7%	$0.66^*	Q3 2023
6/30/2023	0.72%	-1.38%	$1.1M	1.17M	-2,240,255	-65.7%	$0.94	Q2 2023
3/31/2023	2.72%	+0.04%	$3.26M	3.41M	+51,681	+1.54%	$0.96	Q1 2023
12/31/2022	4%	+0.72%	$4.63M	3.36M	+603,495	+21.9%	$1.38	Q4 2022
9/30/2022	3.1%	+2.63%	$3.44M	2.75M	+2,331,012	+553%	$1.25	Q3 2022
6/30/2022	0.85%	+0.64%	$995K	421K	+315,906	+299%	$2.36	Q2 2022
3/31/2022	0.3%	+0.3%	$327K	106K	+105,504	NEW	$3.10	Q1 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.